Skip to Content
MilliporeSigma
  • Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features.

Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features.

Clinical toxicology (Philadelphia, Pa.) (2014-10-28)
Sergey Zakharov, Daniela Pelclova, Pavel Urban, Tomas Navratil, Pavel Diblik, Pavel Kuthan, Jaroslav A Hubacek, Michal Miovsky, Jiri Klempir, Manuela Vaneckova, Zdenek Seidl, Alexander Pilin, Zdenka Fenclova, Vit Petrik, Katerina Kotikova, Olga Nurieva, Petr Ridzon, Jan Rulisek, Martin Komarc, Knut Erik Hovda
ABSTRACT

Methanol poisonings occur frequently globally, but reports of larger outbreaks where complete clinical and laboratory data are reported remain scarce. The objective of the present study was to report the data from the mass methanol poisoning in the Czech Republic in 2012 addressing the general epidemiology, treatment, and outcomes, and to present a protocol for the use of fomepizole ensuring that the antidote was provided to the most severely poisoned patients in the critical phase. A combined prospective and retrospective case series study of 121 patients with confirmed methanol poisoning. From a total of 121 intoxicated subjects, 20 died outside the hospital and 101 were hospitalized. Among them, 60 survived without, and 20 with visual/CNS sequelae, whereas 21 patients died. The total and hospital mortality rates were 34% and 21%, respectively. Multivariate regression analysis found pH < 7.0 (OR 0.04 (0.01-0.16), p < 0.001), negative serum ethanol (OR 0.08 (0.02-0.37), p < 0.001), and coma on admission (OR 29.4 (10.2-84.6), p < 0.001) to be the only independent parameters predicting death. Continuous hemodialysis was used more often than intermittent hemodialysis, but there was no significant difference in mortality rate between the two [29% (n = 45) vs 17% (n = 30), p = 0.23]. Due to limited stockpiles of fomepizole, ethanol was administered more often; no difference in mortality rate was found between the two [16% (n = 70) vs. 24% (n = 21), p = 0.39]. The effect of folate administration both on the mortality rate and on the probability of visual sequelae was not significant (both p > 0.05). Severity of metabolic acidosis, state of consciousness, and serum ethanol on admission were the only significant parameters associated with mortality. The type of dialysis or antidote did not appear to affect mortality. Recommendations that were issued for hospital triage of fomepizole administration allowed conservation of valuable antidote in this massive poisoning outbreak for those patients most in need.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethanol, ≥99.5%, suitable for absorption spectrum analysis
Pricing and availability is not currently available.
Sigma-Aldrich
Ethanol, JIS 300, ≥99.5%, suitable for residue analysis
Pricing and availability is not currently available.
Sigma-Aldrich
Ethanol, ≥99.5%, suitable for HPLC
Pricing and availability is not currently available.
Sigma-Aldrich
Ethanol, ≥99.5%
Pricing and availability is not currently available.
Sigma-Aldrich
Ethanol, ≥99.5%, SAJ super special grade
Pricing and availability is not currently available.
Sigma-Aldrich
Ethanol, JIS 1000, ≥99.5%, suitable for residue analysis
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide, pkg of 10 mg (per vial)
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide, pkg of 50 mg (per vial)
Pricing and availability is not currently available.
Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, anhydrous, ≥99.5%
Pricing and availability is not currently available.
Sigma-Aldrich
Ethyl alcohol, denatured, denatured, reagent grade
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide, pkg of 20 mg (per vial)
Pricing and availability is not currently available.
Sigma-Aldrich
Fomepizole, 99%
Pricing and availability is not currently available.
Sigma-Aldrich
Methanol solution, suitable for NMR (reference standard), 4% in methanol-d4 (99.8 atom % D), NMR tube size 3 mm × 8 in.
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide hydrate, ≥95% (HPLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Ethyl alcohol, Pure, 190 proof, ACS spectrophotometric grade, 95.0%
Pricing and availability is not currently available.
Sigma-Aldrich
Ethyl alcohol, Pure, 190 proof, meets USP testing specifications
Pricing and availability is not currently available.
Sigma-Aldrich
Sodium formate, 99.998% trace metals basis
Pricing and availability is not currently available.
Sigma-Aldrich
Sodium formate, BioUltra, ≥99.0% (NT)
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide hydrate, suitable for cell culture, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide lithium salt from Saccharomyces cerevisiae, ≥95%
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide hydrate, Grade AA-1
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide hydrate, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide hydrate, ≥98%, BioUltra, from yeast
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide hydrate, ≥99%
Pricing and availability is not currently available.
Sigma-Aldrich
4-Methylpyrazole hydrochloride, alcohol dehydrogenase inhibitor
Pricing and availability is not currently available.
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide hydrate, purified by column chromatography, ≥99%
Pricing and availability is not currently available.
Supelco
Ethanol-10, 10 mg/dL in H2O, pack of 10 × 1.2 mL ampules, certified reference material, Cerilliant®
Pricing and availability is not currently available.
Supelco
Ethanol-40, 40 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
Pricing and availability is not currently available.
Supelco
Ethanol-150, 150 mg/dL in H2O, ampule of 10 × 1.2 mL, certified reference material, Cerilliant®
Pricing and availability is not currently available.
Supelco
Methanol solution, contains 0.10 % (v/v) formic acid, UHPLC, suitable for mass spectrometry (MS), ≥99.5%
Pricing and availability is not currently available.